Completed OBSERVATIONAL NCT06390579

Building Research With Artificial Intelligence in Neuro-Ophthalmology (BRAIN)

Sponsor: Fondation Ophtalmologique Adolphe de Rothschild

Conditions Artificial Intelligence (AI) Brain Tumors Deep Learning Machine Learning Optic Atrophy Optic Nerve Diseases Optic Neuritis Optic Neuropathy Optic Neuropathy, Ischemic Papilledema Retinal Photograph

Interventions Deep learning algorithm applied on retrospectively collected color fundus photographs

Updated 4 times since 2024 Last updated: Sep 1, 2025 Started: Oct 1, 2023 Primary completion: Feb 1, 2024 Completion: Feb 1, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Artificial Intelligence (AI) and Brain Tumors and is currently completed. Fondation Ophtalmologique Adolphe de Rothschild leads this study, which shows 4 recorded versions since 2023 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

4 versions recorded

Oct 2025 — Present [monthly]

Completed
Sep 2024 — Oct 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
May 2024 — Jul 2024 [monthly]

Completed

First recorded

Oct 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fondation Ophtalmologique Adolphe de Rothschild

Data source: Fondation Ophtalmologique Adolphe de Rothschild

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Paris, France